Probiotics for infantile colic: Is there evidence beyond doubt? A meta-analysis and systematic review

Sáskia Ribeiro Vaz1, Marise Helena Tofoli2, Melissa Ameloti Gomes Avelino3

  • 1School of Medicine, Federal University of Goiás, Goiânia, Brazil.

Insights

Probiotics and synbiotics significantly reduce daily crying time in infants with colic, offering a promising treatment. Lactobacillus reuteri DSM 17938 and exclusively breastfed infants showed the most notable improvements.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Microbiology

Background:

  • Infantile colic is a common condition affecting infants, characterized by prolonged and inconsolable crying.
  • Probiotics and synbiotics are increasingly explored as therapeutic options for managing infantile colic.
  • Understanding the efficacy of specific probiotic strains and delivery methods is crucial for clinical practice.

Approach:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) were conducted.
  • Literature searches encompassed Embase, PubMed, and Web of Science from 1950 to April 2023.
  • Included RCTs focused on infants under three months with infantile colic, comparing probiotics/synbiotics against placebo or no intervention.

Key Points:

  • Probiotics demonstrated an average reduction of 51 minutes of crying per day (p=0.001).
  • Significant crying reductions were observed in infants born vaginally (-39.30 min), those receiving Lactobacillus reuteri DSM 17938 (-64.66 min), and exclusively breastfed infants (-74.28 min).
  • Other probiotic strains and mixed feeding also showed significant reductions in crying time.

Conclusions:

  • All evaluated probiotic strains appear effective in treating infantile colic.
  • Exclusively breastfed infants experienced a more substantial decrease in crying duration.
  • Further research is needed to clarify the effectiveness of probiotics in formula-fed and cesarean-born infants.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
181
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
72.1K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
338
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
281